Sign in
4

Changes in Ownership

Rani Therapeutics Holdings, Inc. Filed Acc 0000899243-23-017839

Options or other derivatives

  • CHIEF BUSINESS OFFICER acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McKinley Kate CHIEF BUSINESS OFFICER 2023-05-22 Grant or award · Stock Option (Right to Buy) +250,000 250,000 D: show line 1 in the form
Loading xslF345X05/doc4.xml…